Projected increase in obesity and non‐alcoholic‐steatohepatitis–related liver transplantation waitlist additions in the United States ND Parikh, WJ Marrero, J Wang, J Steuer, EB Tapper, M Konerman, ... Hepatology 70 (2), 487-495, 2019 | 119 | 2019 |
Predictors of deceased donor kidney discard in the United States WJ Marrero, AS Naik, JJ Friedewald, Y Xu, DW Hutton, MS Lavieri, ... Transplantation 101 (7), 1690-1697, 2017 | 70 | 2017 |
Projections in donor organs available for liver transplantation in the U nited S tates: 2014‐2025 ND Parikh, D Hutton, W Marrero, K Sanghani, Y Xu, M Lavieri Liver Transplantation 21 (6), 855-863, 2015 | 39 | 2015 |
Estimated association between organ availability and presumed consent in solid organ transplant LJ DeRoos, WJ Marrero, EB Tapper, CJ Sonnenday, MS Lavieri, ... JAMA network open 2 (10), e1912431-e1912431, 2019 | 33 | 2019 |
Data-driven Markov decision process approximations for personalized hypertension treatment planning GJ Schell, WJ Marrero, MS Lavieri, JB Sussman, RA Hayward MDM policy & Practice 1 (1), 2381468316674214, 2016 | 28 | 2016 |
Assessment of national organ donation rates and organ procurement organization metrics LJ DeRoos, Y Zhou, WJ Marrero, EB Tapper, CJ Sonnenday, MS Lavieri, ... JAMA surgery 156 (2), 173-180, 2021 | 20 | 2021 |
Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases WJ Marrero, MS Lavieri, JB Sussman Health Care Management Science 24, 1-25, 2021 | 13 | 2021 |
Population-based analysis and projections of liver supply under redistricting ND Parikh, WJ Marrero, CJ Sonnenday, AS Lok, DW Hutton, MS Lavieri Transplantation 101 (9), 2048-2055, 2017 | 10 | 2017 |
Interpretable policies and the price of interpretability in hypertension treatment planning GGP Garcia, LN Steimle, WJ Marrero, JB Sussman Manufacturing & Service Operations Management 26 (1), 80-94, 2024 | 8 | 2024 |
The magnitude of the health and economic impact of increased organ donation on patients with end-stage renal disease HF Chen, H Ali, WJ Marrero, ND Parikh, MS Lavieri, DW Hutton MDM policy & practice 6 (2), 23814683211063418, 2021 | 8 | 2021 |
Identifying key risk factors for premature discontinuation of opioid use disorder treatment in the United States: A predictive modeling study C Stafford, WJ Marrero, RB Naumann, KH Lich, S Wakeman, MS Jalali Drug and Alcohol Dependence 237, 109507, 2022 | 6 | 2022 |
Development of a Predictive Model for Deceased Donor Organ Yield WJ Marrero, MS Lavieri, SD Guikema, DW Hutton, ND Parikh Transplantation 102 (8), e364, 2018 | 3 | 2018 |
A simulation model to evaluate the implications of genetic testing in cholesterol treatment plans WJ Marrero, MS Lavieri, JB Sussman 2019 Winter Simulation Conference (WSC), 1020-2031, 2019 | 2 | 2019 |
A machine learning approach for the prediction of overall deceased donor organ yield WJ Marrero, MS Lavieri, SD Guikema, DW Hutton, ND Parikh Surgery 170 (5), 1561-1567, 2021 | 1 | 2021 |
Data-Driven Ranges of Near-Optimal Actions for Finite Markov Decision Processes WJ Marrero, MS Lavieri, JB Sussman, RA Hayward Optimization Online, 1-60, 2021 | 1 | 2021 |
Cost-effectiveness and decision analysis of polygenic risk scores in statin use for primary prevention J Sussman, W Marrero, J Burke, M Lavieri, RA Hayward Circulation: Cardiovascular Quality and Outcomes 11 (suppl_1), A101-A101, 2018 | 1 | 2018 |
A Survey on Optimization and Machine-learning-based Fair Decision Making in Healthcare Z Chen, WJ Marrero medRxiv, 2024.03. 16.24304403, 2024 | | 2024 |
Optimizing Interpretable Treatment and Screening Policies in Healthcare AK McNealey, WJ Marrero, LN Steimle, GGP Garcia Encyclopedia of Optimization, 1-14, 2023 | | 2023 |
Towards precision well-being in medical education T Thesen, W Marrero, A Konopasky, M Duncan, KE Blackmon medRxiv, 2023.06. 18.23291549, 2023 | | 2023 |
Machine learning-based prediction of depression severity among medical students D Liu, Z Chen, WJ Marrero, T Thesen medRxiv, 2023.12. 14.23299975, 2023 | | 2023 |